PREVAIL_1A | R Documentation |
Kaplan-Meier digitized data from PREVAIL, figure 1A (PMID 24881730). A reported sample size of 1,717 for a primary endpoint of PFS/OS in prostate cancer.
PREVAIL_1A
A data frame of 1,633 observations and 3 variables:
time | event time (in months) | |
event | RPFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (enzalutamide, placebo) | |
Beer TM, Armstrong AJ, Rathkopf DE, et al. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med 2014; 371: 424–33.
summary(PREVAIL_1A)
kmplot(PREVAIL_1A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.